References in periodicals archive ?
Furthermore there is no need to have it performed in the institution that performed the medical abor- tion.2 Series of studies have compared reliability and safety of ultrasound and measurement of hCG to confirm complete abortion. Some studies have con- cluded that measurement of serial hCG is preferred than ultrasound.12 Some studies showed similar ef- ficacy13 and some emphasized on supplementation of these measures with clinical assessment.1415 The aim of the present study was to compare the useful- ness of serum AY-hCG measurement and ultrasound examination to predict completeness of abortion af- ter medical induction.
The Miscarriage Treatment (MIST) trial randomized 1200 women with a diagnosis of embryonic demise or in complete abortion at <13 weeks to medical (n=398), expectant (n=399), or vacuum aspiration management (n=403).
(90) This indicates that the dose of RU 486 required to induce a complete abortion may change with increasing body mass; or possibly that safety and effectiveness of RU 486 cannot be achieved in the obese population.
Outcome was measured as complete abortion (requiring no surgical intervention), incomplete abortion (clinical and USG evidence), missed abortion and ongoing pregnancy.
Misoprostol was highly effective as an abortificiant with 88% patients achieving complete abortion within 36 hours.
* A complete abortion was defined as complete expulsion of products of conception, while an incomplete abortion was the retention of fetal tissue in the uterus, resulting in the need for uterine evacuation; both were determined clinically.
A PAC patient was defined as any woman presenting with a diagnosis of incomplete, inevitable, missed, or complete abortion, and does not include women seeking induced services.
Of the 23 women whose pregnancies were confirmed, only three reported a complete abortion not requiring further attention.
Since 1996, abortion rates declined by at least 2% per year in 12 of the 28 countries with complete abortion counts and trend data, and rates increased by this much in two countries.
* OUTCOMES MEASURED Rates of surgery, days to complete abortion, pain scores, days of bleeding, side effects, complications, and acceptability.
The efficacy as judged by complete abortion was 88% in group A and 94% in group B.